Serial Percutaneous Liver Biopsies in Laboratory Rats

I. R. Corbin, G. Y. Minuk

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

The percutaneous liver biopsy is an essential tool that provides histological assessment of the liver for diagnostic, therapeutic, and prognostic purposes. To date, this procedure has not been described in the laboratory setting for studies with small laboratory animals. The aim of the present study was to assess the feasibility and diagnostic value of performing serial percutaneous liver biopsies in a rat model of chronic liver disease. Adult male Sprague-Dawley rats (N = 27) were exposed to thioacetamide (TAA) for six months, throughout which serial liver biopsies were performed at baseline and two, four, and six months. An additional group of isocaloric-fed rats (N = 6) not exposed to TAA served as controls. Following the biopsies at each time point, a subset of rats was killed to determine whether the histologic findings seen in the biopsies were consistent with the histology of the entire organ. Seven rats (21%) died from complications of the procedure (one from anaesthetic overdose and six from postbiopsy bleeding). A total of 72 biopsies were performed, resulting in a procedural mortality of 8%. In the remaining rats, biopsies were well tolerated with no overt signs of pain or discomfort. Histologic activity and fibrosis in the biopsy specimens reflected the results observed in wedge sections of liver tissue at all stages of TAA-induced liver disease. The results of this study indicate that serial percutaneous liver biopsies can be successfully performed and reflect the extent of hepatic injury in a common model of chronic liver disease.

Original languageEnglish (US)
Pages (from-to)1939-1943
Number of pages5
JournalDigestive Diseases and Sciences
Volume48
Issue number10
DOIs
StatePublished - Oct 2003

Fingerprint

Biopsy
Liver
Thioacetamide
Liver Diseases
Chronic Disease
Laboratory Animals
Sprague Dawley Rats
Anesthetics
Histology
Fibrosis
Hemorrhage
Pain
Mortality
Wounds and Injuries

Keywords

  • Chronic liver disease
  • Cirrhosis
  • Liver
  • Liver biopsy
  • Rat
  • Thioacetamide

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Serial Percutaneous Liver Biopsies in Laboratory Rats. / Corbin, I. R.; Minuk, G. Y.

In: Digestive Diseases and Sciences, Vol. 48, No. 10, 10.2003, p. 1939-1943.

Research output: Contribution to journalArticle

@article{855f99a1b96f49a995c3e5e3e1a0c46d,
title = "Serial Percutaneous Liver Biopsies in Laboratory Rats",
abstract = "The percutaneous liver biopsy is an essential tool that provides histological assessment of the liver for diagnostic, therapeutic, and prognostic purposes. To date, this procedure has not been described in the laboratory setting for studies with small laboratory animals. The aim of the present study was to assess the feasibility and diagnostic value of performing serial percutaneous liver biopsies in a rat model of chronic liver disease. Adult male Sprague-Dawley rats (N = 27) were exposed to thioacetamide (TAA) for six months, throughout which serial liver biopsies were performed at baseline and two, four, and six months. An additional group of isocaloric-fed rats (N = 6) not exposed to TAA served as controls. Following the biopsies at each time point, a subset of rats was killed to determine whether the histologic findings seen in the biopsies were consistent with the histology of the entire organ. Seven rats (21{\%}) died from complications of the procedure (one from anaesthetic overdose and six from postbiopsy bleeding). A total of 72 biopsies were performed, resulting in a procedural mortality of 8{\%}. In the remaining rats, biopsies were well tolerated with no overt signs of pain or discomfort. Histologic activity and fibrosis in the biopsy specimens reflected the results observed in wedge sections of liver tissue at all stages of TAA-induced liver disease. The results of this study indicate that serial percutaneous liver biopsies can be successfully performed and reflect the extent of hepatic injury in a common model of chronic liver disease.",
keywords = "Chronic liver disease, Cirrhosis, Liver, Liver biopsy, Rat, Thioacetamide",
author = "Corbin, {I. R.} and Minuk, {G. Y.}",
year = "2003",
month = "10",
doi = "10.1023/A:1026228018643",
language = "English (US)",
volume = "48",
pages = "1939--1943",
journal = "Digestive Diseases and Sciences",
issn = "0163-2116",
publisher = "Springer New York",
number = "10",

}

TY - JOUR

T1 - Serial Percutaneous Liver Biopsies in Laboratory Rats

AU - Corbin, I. R.

AU - Minuk, G. Y.

PY - 2003/10

Y1 - 2003/10

N2 - The percutaneous liver biopsy is an essential tool that provides histological assessment of the liver for diagnostic, therapeutic, and prognostic purposes. To date, this procedure has not been described in the laboratory setting for studies with small laboratory animals. The aim of the present study was to assess the feasibility and diagnostic value of performing serial percutaneous liver biopsies in a rat model of chronic liver disease. Adult male Sprague-Dawley rats (N = 27) were exposed to thioacetamide (TAA) for six months, throughout which serial liver biopsies were performed at baseline and two, four, and six months. An additional group of isocaloric-fed rats (N = 6) not exposed to TAA served as controls. Following the biopsies at each time point, a subset of rats was killed to determine whether the histologic findings seen in the biopsies were consistent with the histology of the entire organ. Seven rats (21%) died from complications of the procedure (one from anaesthetic overdose and six from postbiopsy bleeding). A total of 72 biopsies were performed, resulting in a procedural mortality of 8%. In the remaining rats, biopsies were well tolerated with no overt signs of pain or discomfort. Histologic activity and fibrosis in the biopsy specimens reflected the results observed in wedge sections of liver tissue at all stages of TAA-induced liver disease. The results of this study indicate that serial percutaneous liver biopsies can be successfully performed and reflect the extent of hepatic injury in a common model of chronic liver disease.

AB - The percutaneous liver biopsy is an essential tool that provides histological assessment of the liver for diagnostic, therapeutic, and prognostic purposes. To date, this procedure has not been described in the laboratory setting for studies with small laboratory animals. The aim of the present study was to assess the feasibility and diagnostic value of performing serial percutaneous liver biopsies in a rat model of chronic liver disease. Adult male Sprague-Dawley rats (N = 27) were exposed to thioacetamide (TAA) for six months, throughout which serial liver biopsies were performed at baseline and two, four, and six months. An additional group of isocaloric-fed rats (N = 6) not exposed to TAA served as controls. Following the biopsies at each time point, a subset of rats was killed to determine whether the histologic findings seen in the biopsies were consistent with the histology of the entire organ. Seven rats (21%) died from complications of the procedure (one from anaesthetic overdose and six from postbiopsy bleeding). A total of 72 biopsies were performed, resulting in a procedural mortality of 8%. In the remaining rats, biopsies were well tolerated with no overt signs of pain or discomfort. Histologic activity and fibrosis in the biopsy specimens reflected the results observed in wedge sections of liver tissue at all stages of TAA-induced liver disease. The results of this study indicate that serial percutaneous liver biopsies can be successfully performed and reflect the extent of hepatic injury in a common model of chronic liver disease.

KW - Chronic liver disease

KW - Cirrhosis

KW - Liver

KW - Liver biopsy

KW - Rat

KW - Thioacetamide

UR - http://www.scopus.com/inward/record.url?scp=0242570897&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0242570897&partnerID=8YFLogxK

U2 - 10.1023/A:1026228018643

DO - 10.1023/A:1026228018643

M3 - Article

C2 - 14627337

AN - SCOPUS:0242570897

VL - 48

SP - 1939

EP - 1943

JO - Digestive Diseases and Sciences

JF - Digestive Diseases and Sciences

SN - 0163-2116

IS - 10

ER -